Literature DB >> 2314425

Tryptophan-induced eosinophilia-myalgia syndrome.

T A Medsger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314425     DOI: 10.1056/NEJM199003293221309

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  The eosinophilia-myalgia syndrome.

Authors:  S A Jimenez; J Varga
Journal:  West J Med       Date:  1990-09

2.  Plasma concentrations of tryptophan and dieting.

Authors:  A Brzezinski; N Shalitin; P Ever-Hadani; J G Schenker
Journal:  BMJ       Date:  1990-07-21

Review 3.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

4.  Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.

Authors:  T N James
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

5.  Two cases of neurological manifestations in eosinophilia: variations of one disease?

Authors:  S Ostrowitzki; S Zierz
Journal:  Clin Investig       Date:  1994-12

6.  Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome.

Authors:  M L Freimer; J D Glass; V Chaudhry; W R Tyor; D R Cornblath; J W Griffin; R W Kuncl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

7.  Supraphysiologic L-tryptophan elicits cytoskeletal and macromolecular permeability alterations in hamster small intestinal epithelium in vitro.

Authors:  J L Madara; S Carlson
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.